Vinci Gen S.A. engages in the building and development of an integrated ecosystem of health services using modern genetics and imaging diagnostics in Poland, the European Union and global markets. Its areas of activity are NIPT prenatal diagnostics, genetic cancer diagnostics, artificial intelligence in diagnostics, telemedicine and mobile applications, medical marijuana and supportive therapies, and translational medicine and scientific cooperation. Vinci Gen S.A. was formerly known as Movie Games VR Spólka Akcyjna and changed its name to Vinci Gen S.A. in July 2025. Vinci Gen S.A. was incorporated in 2010 and is headquartered in Warsaw, Poland.
Metrics to compare | VGNP | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipVGNPPeersSector | |
---|---|---|---|---|
P/E Ratio | 55.8x | −3.2x | 9.5x | |
PEG Ratio | 0.20 | 0.08 | 0.03 | |
Price/Book | 50.8x | 1.8x | 1.0x | |
Price / LTM Sales | 73.9x | 2.2x | 2.8x | |
Upside (Analyst Target) | - | 53.1% | 13.1% | |
Fair Value Upside | Unlock | −4.5% | 1.7% | Unlock |